Live from the Medical Expo | Akeso Debuts World's First Dual-Antibody, Leading a New Breakthrough in Tumor Treatment
Author:广州医博会 Time:2025-10-15 Reader:5

The 2025 Guangzhou Medical and Health Industry Expo (hereinafter referred to as "Guangzhou Medical Expo") was grandly held from August 22nd to 24th, gathering many leading enterprises and innovative forces in the medical and health field at home and abroad. At this industry feast, Akeso (9926.HK) became the focus of the audience with its outstanding independent research and development capabilities and breakthrough innovative achievements.

668955507033521(1).jpg

01 In-Depth Dialogue: Innovation-Driven, Accelerating Value Transformation

"Guangzhou Medical Expo has built a deep and efficient interactive bridge for the development of the innovative pharmaceutical industry." Yang Jun, Assistant Vice President of Government Affairs and Market Access of Akeso, said. According to Yang Jun, Cadonilimab and Ivonescimab of Akeso have been included in the National Medical Insurance Catalog, covering core hospitals in all provinces and major cities across the country. "As one of the three major medical centers in the country, Guangzhou is of great strategic significance for the development of innovative drugs. The carefully designed sessions of this medical expo not only integrate product display and academic exchange but also accurately connect enterprise innovation with clinical needs. This medical expo has promoted more accurate cognition of the clinical value of enterprises' innovative cutting-edge methods and also enabled enterprises to capture the latest clinical needs in a timely manner, which is conducive to accelerating the transformation of innovative drugs from research and development to clinical application, effectively promoting the improvement of their accessibility, and has a positive significance for the development of the innovative pharmaceutical industry." Yang Jun said.

Search for the "Guangzhou Medical Expo Official" video account to watch the interview video!

02 Exhibitor Style: Many Heavyweight Innovative Drugs Make a Stunning Appearance

Walking into Akeso's exhibition area, it feels like stepping into a medical technology world full of a sense of the future. Many independently developed heavyweight innovative drugs are neatly arranged, each carrying Akeso's profound insights and unremitting exploration in the field of tumor immunotherapy and other disease treatment. As a biopharmaceutical innovation enterprise with international competitiveness, Akeso has developed more than 50 innovative drug candidates with global independent intellectual property rights, 24 of which have entered the clinical stage, and 7 first-in-class new drugs have successfully been approved for marketing, demonstrating its profound heritage and strong strength in the field of biomedicine.

1761016777649.jpg

At the Guangzhou Medical Expo, two globally pioneering dual-antibody drugs independently developed by Akeso, Cadonilimab Injection and Ivonescimab Injection, became one of the most concerned innovative drugs in this exhibition, triggering key discussions among experts and industry representatives at the meeting.

2f6c993a9e1d4dc723dcaf285cf199f5.jpg

Work Together to Create a New Chapter in Medical Health

At this Guangzhou Medical Expo, Akeso not only demonstrated its outstanding achievements in innovative drug research and development but also further broadened the vision of cooperation and deepened the connotation of cooperation through in-depth exchanges with industry partners, governments, and hospital units. In the future, Akeso will continue to adhere to the development concept driven by innovation, strengthen cooperation and exchanges with all parties, and jointly promote the vigorous development of the medical and health industry.

Although the Guangzhou Medical Expo has ended, Akeso's road of innovation is endless. Let us look forward to Akeso continuing to write its brilliant chapter in the future medical and health field and contributing more wisdom and strength to human health undertakings!


Some content sources: Akeso

END

AkesoWelcome to follow the official account


微信图片_20251015150957.png